The Thesis
HCA Healthcare is a hospital operator that runs medical facilities across the United States and the United Kingdom. The company generated $75.60 billion in revenue last fiscal year, representing growth of 7%, while maintaining 189 hospitals and approximately 2,600 sites of care. The continued expansion into high-growth sunbelt markets and the scaling of ambulatory surgery centers mark the structural shift that makes the current compounding story possible.
What makes this work boils down to a few specific things.
In our view, HCA Healthcare is a multi-year compounder driven by its superior scale and ability to manage labor costs better than smaller peers. The case for owning this only gets stronger if the company can prove its new digital nursing platforms actually lower turnover. We think the current valuation represents a significant opportunity for patient investors.
Numbers at a Glance
What does it do?
HCA Healthcare is a mature business that earns money by providing medical services through its network of hospitals and outpatient centers. The company charges insurance companies, government programs like Medicare, and individual patients for various treatments. This includes everything from emergency room visits and elective surgeries to complex cardiac care and diagnostic imaging. Because HCA owns the entire infrastructure, it captures revenue at every step of the patient journey from the initial clinic visit to the hospital stay.
Where does revenue come from?
The vast majority of revenue comes from inpatient and outpatient services provided at hospitals. This includes daily room charges and surgical fees. Ancillary services like laboratory tests and radiology provide a secondary stream of income. Most of this revenue is concentrated in the United States, with a smaller portion generated from facilities in the United Kingdom.
Revenue Breakdown
Revenue by Geography
Who are its customers?
HCA Healthcare serves millions of patients annually across its 189 hospitals and approximately 2,600 ambulatory sites of care. In the first quarter of 2026, the company reported that same-facility equivalent admissions increased 1.3%. The company also manages high-volume throughput with same-facility emergency room visits growing 0.3% in the same period. While patients are the end-users, the actual payers are primarily private insurance companies and government entities like Medicare and Medicaid.
What gives it staying power?
HCA Healthcare has massive staying power because of its enormous scale and the regulatory barriers that prevent new hospitals from opening. In many states, "Certificate of Need" laws require government approval to build new facilities, which effectively protects HCA's existing markets. This scale allows HCA to negotiate better prices for supplies and labor than its smaller rivals.
Where is it headed?
The single biggest strategic bet HCA is making is the aggressive expansion of its ambulatory surgery network. Management is shifting more procedures to these lower-cost outpatient settings to capture market share from independent clinics. If this works, HCA will lock in more patients before they ever need a hospital bed.
Revenue increased 4.3% in the latest quarter to $19.11 billion, showing the business can grow even through seasonal fluctuations. This steady climb in sales is backed by a 1.3% rise in equivalent admissions. The company consistently turns patient volume into predictable top-line gains.
Free cash flow reached $7.69 billion last year, which closely tracks the $6.78 billion in net income. This high cash quality allows HCA to fund its $1.12 billion in quarterly capital expenditures without relying on outside debt. The business effectively pays for its own growth.
HCA carries $48.02 billion in total debt, but it generates $3.80 billion in quarterly Adjusted EBITDA to cover it. While the leverage appears high in absolute terms, the company's 8.7x EV/EBITDA multiple suggests the debt is well-managed. The steady cash flows make this level of borrowing sustainable.
HCA Healthcare is a financially dominant business with a 18.8% ROIC that proves it can invest capital much more efficiently than its hospital peers.
The company's 18.8% return on invested capital proves that HCA is much better at allocating money than the average hospital operator. This efficiency comes from clustering facilities in high-growth cities where they can share staff and equipment. This strategy creates a cost advantage that competitors simply cannot match.
Labor costs are the single biggest risk, especially if nursing shortages lead to another spike in expensive contract staffing. Management is countering this by opening its own nursing schools and using AI to optimize schedules. If these initiatives fail, the current 34.9% gross margin will likely compress.
The US hospital and healthcare facilities market is roughly $1.4 trillion today, growing at about 4% annually as the population ages. This is a good industry because the demand for healthcare is mostly disconnected from the economic cycle, but pricing power is limited by government reimbursement rates. HCA Healthcare stands as the clear market leader, using its size to win better terms from private insurers while smaller hospitals struggle to stay afloat.
The hospital market is rationally structured because the massive cost of building new facilities prevents aggressive new entry. Pricing power is structural because patients rarely choose a hospital based on price alone. The industry is slowly consolidating as large networks like HCA acquire smaller, distressed independent hospitals.
Tenet Healthcare(THC) is the most direct threat because they are also aggressively shifting their focus toward high-margin ambulatory surgery centers. Universal Health Services(UHS) competes heavily in the behavioral health space where HCA is trying to grow. The most dangerous threat is the rise of outpatient-only competitors who can perform surgeries at lower prices than a full-scale hospital.
HCA Healthcare is holding its ground and gaining share in the outpatient market. Same-facility equivalent admissions grew 1.3% last quarter, proving that patients are choosing HCA facilities over local alternatives.
The primary source of protection is efficient scale, which allows HCA to spread its fixed costs across a massive patient base. This scale is reinforced by regulatory moats like Certificate of Need laws that prevent competitors from building new hospitals nearby. HCA's 18.8% ROIC is the single most compelling evidence that this scale creates a real financial barrier.
The combination of high ROIC and steady 34.9% gross margins proves that HCA's advantage is structural rather than a lucky streak. These numbers have remained resilient even as labor costs spiked across the industry. The data shows a durable advantage that allows HCA to out-earn its competitors in almost any economic environment.
The moat is strengthening as HCA builds out its ambulatory network to lock in patients earlier. The scale of this network makes it nearly impossible for smaller rivals to compete on price or convenience.
Consistently grew revenue 7% and reached $7.15 EPS in Q1 2026.
Repurchased 3.157 million shares for $1.571 billion in Q1 2026 alone.
CEO Hazen has served for over 40 years, deeply embedding his incentives.
Capital Allocation Track Record
Samuel N. Hazen has proven to be an exceptional leader by focusing on operational efficiency and aggressive share repurchases. Under his direction, HCA has successfully navigated a difficult labor market while expanding into more profitable outpatient services. The decision to return $1.57 billion to shareholders in a single quarter shows a management team that is highly focused on maximizing investor value.
© 2026 ClearThesis.ai · Report generated on May 27, 2026
This is an AI-generated analysis for informational purposes only and does not constitute financial advice. Data and analysis may not reflect recent developments if viewed significantly after the generation date. Always conduct your own due diligence before making any investment decisions.